Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Net Cash Flow (2019 - 2025)

Historic Net Cash Flow for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to -$9.5 million.

  • Korro Bio's Net Cash Flow rose 6616.57% to -$9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.8 million, marking a year-over-year decrease of 33879.33%. This contributed to the annual value of -$114.1 million for FY2024, which is 18664.86% down from last year.
  • As of Q3 2025, Korro Bio's Net Cash Flow stood at -$9.5 million, which was up 6616.57% from -$30.5 million recorded in Q2 2025.
  • In the past 5 years, Korro Bio's Net Cash Flow ranged from a high of $121.8 million in Q4 2023 and a low of -$51.1 million during Q1 2021
  • For the 5-year period, Korro Bio's Net Cash Flow averaged around -$10.4 million, with its median value being -$18.2 million (2023).
  • In the last 5 years, Korro Bio's Net Cash Flow crashed by 120295.64% in 2021 and then skyrocketed by 189737.39% in 2023.
  • Korro Bio's Net Cash Flow (Quarter) stood at -$32.4 million in 2021, then skyrocketed by 79.1% to -$6.8 million in 2022, then skyrocketed by 1897.37% to $121.8 million in 2023, then tumbled by 107.66% to -$9.3 million in 2024, then fell by 1.36% to -$9.5 million in 2025.
  • Its last three reported values are -$9.5 million in Q3 2025, -$30.5 million for Q2 2025, and $8.5 million during Q1 2025.